Background
==========

Cerebral ischemic stroke (CIS) is a major cause of morbidity and mortality, and is expected to remain so until at least 2030 \[[@b1-medscimonit-20-1758]\]. CIS and coronary heart disease (CHD) are major manifestations of atherosclerotic processes. High plasma levels of low-density lipoprotein cholesterol (LDL-C) have consistently been shown to be a risk factor for the development of atherosclerosis \[[@b2-medscimonit-20-1758]\]. Plasma concentrations of LDL-C are determined primarily by the activity of the LDL receptor (LDLR) in the liver. Proprotein convertase subtilisin-like kexin type 9 (PCSK9) was recently discovered to be a major factor in cholesterol homeostasis through enhanced degradation of LDLR \[[@b3-medscimonit-20-1758]--[@b6-medscimonit-20-1758]\] and possibly in neural development. However, both rare mutations and common variants in the coding regions of PCSK9 can affect LDL cholesterol levels and stroke risk. Recent studies identified several PCSK9 variants influencing circulating LDL-C levels \[[@b7-medscimonit-20-1758],[@b8-medscimonit-20-1758]\]. Since the first identification mutation of PCSK9 was implicated in autosomal dominant hypercholesterolemia by Abifadel \[[@b9-medscimonit-20-1758]\], more than 53 missense variants have been identified. A common SNP, E670G (rs505151) in exon 12 of PCSK9, results in the substitution of glutamate for a glycine residue at position 670 in the protein \[[@b10-medscimonit-20-1758]\] Carriers of 670 Gln in the general population presented increased plasma TC, LDL-C, and ApoB levels. Another study suggested a key role played by the E670G polymorphism in determining plasma LDL-C levels and the severity of coronary atherosclerosis in the United States \[[@b11-medscimonit-20-1758]\]. More recently, the presence of the 670G allele was significantly associated with an increased risk of large-vessel atherosclerosis (LVA) stroke \[[@b12-medscimonit-20-1758]\] and intimal media thickness (IMT) \[[@b13-medscimonit-20-1758]\]. However, these studies were inconsistent with previous studies \[[@b14-medscimonit-20-1758]--[@b16-medscimonit-20-1758]\], which were conducted in Caucasian and African populations and failed to find this association. Furthermore, the carriers of 670G showed significantly increased LDL in men but not in women in a European population \[[@b17-medscimonit-20-1758]\]. In addition, the rs72555377 insertion polymorphism in exon 1 of PCSK9 is associated with lower LDL-C in Caucasian populations \[[@b18-medscimonit-20-1758]\], while the L11 allele, with insertion of 2 Leucines, is associated with higher LDL-C \[[@b11-medscimonit-20-1758]\], and rs562556 (Ile474Val) in exon9 of the PCSK9 gene is associated with approximately 7% lower LDL cholesterol levels in carriers in a Japanese population \[[@b19-medscimonit-20-1758]\].

In our study, we used a single-base terminal extension (SNaPshot) method to detect the genotypes of the 20 single-nucleotide polymorphisms (SNP) in the PCSK9 gene to assess the association between the human PCSK9 gene polymorphism and CIS in members of the Han and Uygur populations of China.

Material and Methods
====================

Ethics approval of the study protocol
-------------------------------------

Written informed consent was obtained from all participants. All participants explicitly provided permission for DNA analyses as well as collection of relevant clinical data. This study was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University, Urumqi, China (NO. 20120510). It was conducted according to the standards of the Declaration of Helsinki.

Subjects
--------

Subjects were from a Han population and a Uygur population who lived in the Xinjiang Uygur Autonomous Region of China. We recruited the CIS group from the First Affiliated Hospital of Xinjiang Medical University Neurology Department between since October 2011 and May 2012, and the control group came from the same hospital in the same period.

In the CIS group, there were 408 CIS patients (158 Uygur, 250 Han), mean age 61.97±11.80 years. Inclusion criteria were: (1) diagnosed in accordance with the standards set at 10 international classifications of diseases (ICD10); (2) confirmed by MRI. Exclusion criteria were: (1) patients with CHD; (2) hemorrhagic cerebrovascular disease confirmed by CT or MRI; (3) refused to participate in trials.

In the Control group there were 348 of healthy controls (149 Uygur, 199 Han), mean age 61.84±11.65 years. Inclusion criteria were: (1) aged \>40; (2) no known family history of cerebrovascular disease; (3) the cardiopulmonary physical examination and nervous system examination did not find abnormalities; (4) MRI negative except for cerebrovascular disease. Exclusion criteria: acute or chronic infection, malignant tumor, autoimmune diseases.

Clinical characteristics of the study participants
--------------------------------------------------

All patients completed the standard test registration form, and disclosed the following data: (1) General information: age, sex, race. (2) Personal history: smoking history (daily average smoking, smoking an average of ≥1 day or more, time \>1 year, defined as smoking), (drinking alcohol an average of ≥3 times per week, more than 50 g each time \>1 year, defined as drinking), hypertension, diabetes, hyperlipidemia, transient ischemic attack (TIA), atrial fibrillation (AF), heart valve disease, heart valve replacement, peripheral vascular disease. Hypertension: the Seventh World Health Organization /International Society of Hypertension League Conference defined the new standard for the diagnosis of hypertension; in our study, the diagnosis of hypertension was established if patients were treated with antihypertensive medication or if the mean of 3 measurements of systolic blood pressure (SBP) \>140 mm Hg or diastolic blood pressure (DBP) \>90 mm Hg, respectively. Diabetes mellitus was diagnosed according to the criteria of the American Diabetes Association \[[@b20-medscimonit-20-1758]\]. Individuals with daytime random blood glucose ≥11.1 mmol/l or after fasting glucose ≥7.0mmol/l or glucose in line 2 h ≥11.1mmol/l or with a history of diabetes or treatment with insulin were considered diabetic. (3) Medical history prior to admission: treatment with antihypertensive drugs, antiplatelet drugs and anticoagulants, diabetes, lipid drug, anti-seizure medication, birth control pills, hormones. (4) Family history: whether grandparents, parents, siblings, and children had hypertension, diabetes, cerebral hemorrhage, cerebral infarction, myocardial infarction, coronary heart disease, or arrhythmia incidence. (5) Physical examination: height, weight, blood pressure, pulse, temperature. (6) Special tests: electrocardiogram, chest X-ray, heart neck ultrasound, blood routine, blood glucose, blood lipids.

Biochemical analysis
--------------------

Serum concentrations of total cholesterol (TC), triglyceride (TG), glucose (Glu), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C), apolipo protein A1 (ApoA1), apolipo protein B (ApoB), and apolipo lipoprotein a (ApoLpa) were measured using standard methods in the Central Laboratory of First Affiliated Hospital of Xinjiang Medical University.

Blood collection and DNA extraction
-----------------------------------

Fasting blood samples (5 mL) drawn by venipuncture were taken from all participants early in the morning. The blood samples were drawn into a 5-mL ethylene diamine tetraacetic acid (EDTA) tube and centrifuged at 4000×g for 5 min to separate the plasma content. Genomic DNA was extracted from the peripheral leukocytes using standard phenol-chloroform method. The DNA samples were stored at −80°C until use, then diluted to 50 ng/μL concentration.

SNaPshot Reactions
------------------

We selected the genotypes of the 20 SNPs in the PCSK9 gene using the Haploview 4.2 software and the HapMap phrase II database by using minor allele frequency (MAF) ≤0.1 and linkage disequilibrium patterns with r2 ≥0.5 as a cut-off. The position of the 20 SNPs was by order of increasing distance from the gene PCSK9 5′ end ([Table 1](#t1-medscimonit-20-1758){ref-type="table"}). We used single-base terminal extension (SNaPshot) method to genotype. SNaPshot reactions were performed as described by the manufacturer (Applied Biosystems, Warrington, UK). Briefly, 4.0-μl of PCR product was incubated at 37°C for 60 min with 2-U shrimp alkaline phosphatase (SAP) and 2-U Exonuclease I (ExoI). Following a 15-min incubation to inactivate the enzymes, 1 ul of digested PCR product was mixed with 5 ul of ready reaction premix, 1 ul of 1.0- UM primer ([Table 1](#t1-medscimonit-20-1758){ref-type="table"}), and 3 ul of dH2O. This mixture was placed in the thermal cycler and underwent 25 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for 30 s. When completed, 0.5-U SAP was added and the reaction mixture was incubated for 60 min. Prior to loading onto the PRISM 310, 10 ul of formamide was added to 1 ul of reaction mixture and samples were heated to 95°C for 5 min.

Statistical analysis
--------------------

All continuous variables (e.g., age, BMI, pulse, and cholesterol levels) are presented as means ± standard deviation (S.D.). The difference between the CIS and control groups was analyzed using an independent-sample T-test. The differences in the frequencies of sex, hypertension, diabetes mellitus, smoking, drinking, and genotypes were analyzed using chi-square test or Fisher's exact test, as appropriate. Hardy-Weinberg equilibrium was assessed by chi-square analysis. Logistic regression analyses with effect ratios (odds ratio \[OR\] and 95% CI) were used to assess the contribution of the major risk factors. All statistical analyses were performed using SPSS 17.0 for Windows (SPSS Institute, Chicago, USA). Haplotypes were estimated using the SHEsis platform \[[@b21-medscimonit-20-1758],[@b22-medscimonit-20-1758]\]. P-values of less than 0.05 were considered to be statistically significant.

Results
=======

[Table 2](#t2-medscimonit-20-1758){ref-type="table"} showed the clinical characteristics of the CIS patients (n=408) and control participants (n=348). For all Han and Uygur subjects, there were no significant differences in age and sex between CIS patients and control subjects, indicating the study was an age- and sex-matched case-control study. We observed several differences between the groups of patients. As expected, several common risk factors for CIS were significantly different between the 2 subgroups: Glu, low HDL-C, high LDL-C, EH, and DM. Other CIS risk factors, such as high TC, TG levels, and cigarette smoking and drinking, were not significantly different.

[Table 1](#t1-medscimonit-20-1758){ref-type="table"} shows the basic information and the distribution of genotypes and alleles of the 20 SNPs for the PCSK9 gene. The position of the 20 SNPs was by order of increasing distance from the gene PCSK9 5′ end. We observed that the distribution of genotypes and alleles of 3 SNPs (SNP1, SNP2, and SNP8) were significantly different between CIS group and control participants. All SNPs were consistent with Hardy-Weinberg expectations (data not shown).

The 3 SNPs among the 3 groups (Total, Han, and Uyghur) were examined by Hardy-Weinberg equilibrium test and no significant differences were found in these 3 groups (data not shown).

In the study, we confirmed the distribution of genotypes and alleles of the 3 SNPs (SNP1, SNP2, and SNP8) for the PCSK9 gene. For SNP1 (rs17111503), the distribution of alleles showed a significant difference between CIS and control participants (P=0.028) in the Han group, but not in the total group and Uygur group. For SNP2 (rs2479408), the distribution of alleles, the dominant model (CC *vs.* CG + GG), and the additive model (CG *vs.* CC + GG) showed a significant difference between CIS and control participants in total and Han groups, but not in the Uygur group. C allele of rs2479408 was significantly higher in CIS patients than in control participants (total: 96.94% *vs.* 94.97%; Han: 99.80% *vs.* 98.24%). For SNP3 (rs529787), the distribution of alleles, the dominant model (CC *vs.* CG + GG) and the additive model (CG *vs.* CC + GG) showed a significant difference between CIS and control participants in the total and Han groups, but not in the Uygur group. C allele of rs529787 was significantly higher in CIS patients than in control participants (Total: 96.81% *vs.* 94.68%; Han: 99.80% *vs.* 97.99%) (data no shown).

[Table 3](#t3-medscimonit-20-1758){ref-type="table"} and [Figure 1](#f1-medscimonit-20-1758){ref-type="fig"} show patterns of linkage disequilibrium in the PCSK9 gene, with their \|D′\| and r^2^ values. \|D′\| values from 0.7 to 1 indicate strong LD between a pair of SNPs. \|D′\| values from 0.25 to 0.7 indicate moderate LD and \|D′\| values of 0--0.25 indicate low LD. In the study, 3 strong LD patterns were observed between SNP1 and SNP2 (\|D′\|=0.999), SNP2 and SNP8 (\|D′\|=0.983), and SNP1 and SNP8 (\|D′\|=0.999). We consider that all 3 SNPs were located in 1 haplotype block. The *r*^2^ value of SNP2--SNP8 \>0.5 means the SNP2 and SNP8 can replace each other \[[@b11-medscimonit-20-1758]\] and they cannot construct haplotypes simultaneously. Therefore, given that the position of SNP1 and SNP2 are both in 2KB upstream of PCSK9 gene and the position of SNP8 is in intron3, we constructed the haplotypes using SNP1 and SNP2.

[Table 4](#t4-medscimonit-20-1758){ref-type="table"} shows the distribution of haplotypes in CIS patient and control participants. There were 4 haplotypes established in all subjects. The overall distribution of the haplotypes were significantly different between the CIS patients and the control subjects (all P\<0.05). The most frequent haplotype in this study was A-C haplotype. For Han, the frequency of A-C was significantly higher in the CIS patients than in the control subjects (P=0.0011). In addition, the frequency of the G-C haplotype was lower in the CIS patients than in the control subjects (P=0.0011).

[Table 5](#t5-medscimonit-20-1758){ref-type="table"} showed that multiple logistic regression analyses were performed with age, sex, BMI, HDL-C, LDL-C, TC, TG, ApoA1 ApoB, ApoLpa, EH, DM, and smoking and drinking, because these variables were the major confounding factors for CIS. The significant difference of the dominant model (CC *vs.* CG + GG) of rs2479408 was retained after adjustment for covariates in the Han, but not in the Uygur group (OR: 75.262, 95% confidence interval \[CI\]: 7.232--783.278, P\<0.001).

Discussion
==========

PCSK9, also known as neural apoptosis-regulated convertase 1 (NARC1), is the ninth member of the proprotein convertase (PC) family \[[@b23-medscimonit-20-1758]\]. The human PCSK9 gene is located on chromosome 1p32.3; it encompasses 12 exons and encodes a 692 amino acid glycoprotein. PCSK9 is synthesized as an inactive zymogen, pro-PCSK9 (73 kDa) and contains a signal peptide, a prodomain (residues 31--152) and a catalytic domain (residues 153--451) followed by a C-terminal domain (residues 452--692) \[[@b24-medscimonit-20-1758]\]. PCSK9 acts as a serine protease and molecular chaperone that reduces both hepatic and extrahepatic low-density lipoprotein receptor levels through an endosomal/lysosomal pathway and increases plasma LDL cholesterol \[[@b4-medscimonit-20-1758],[@b25-medscimonit-20-1758]\]. PCSK9 may also regulate apolipoprotein B-containing lipoprotein production and apoB secretion \[[@b26-medscimonit-20-1758],[@b27-medscimonit-20-1758]\].

Recent advances revealed a large number of genetic variants of PCSK9 that may modulate plasma cholesterol levels either positively or negatively. "Gain of function" missense mutations in PCSK9 were associated with autosomal-dominant hypercholesterolemia (ADH), a rare form of familial hypercholesterolemia (FH) in which neither the LDLR nor the ligand binding domain of apolipoprotein (apo) B100 are mutated \[[@b28-medscimonit-20-1758],[@b29-medscimonit-20-1758]\]. "Loss of function" nonsense mutations in PCSK9 were associated with low plasma LDL-C levels and a reduced incidence of cardiovascular disease \[[@b30-medscimonit-20-1758],[@b31-medscimonit-20-1758]\]. Later, many *in vitro* and *in vivo* overexpression and knockout/knockdown studies confirmed that PCSK9 targets the LDLR for degradation \[[@b32-medscimonit-20-1758]--[@b34-medscimonit-20-1758]\]. Studies have confirmed that both rare mutations and common variants in the coding regions of PCSK9 affect LDL cholesterol levels and stroke risk. In this study, we selected 20 SNPs of PCSK9 and used case-control analyses to assess the association between the human PCSK9 gene polymorphism and CIS in the Han and Uygur populations.

Our findings showed the distribution of SNP8 (rs529787) genotypes were significantly different between CIS and control participants (P=0.049). However, when analyzing Han and Uygur groups separately, we found that only in the Han population was the distribution of SNP1 (rs1711503), SNP2 (rs2479408), and SNP8 (rs529787) alleles significantly different between CIS and control participants (P=0.028, P=0.013, P=0.006, respectively). For SNP1 (rs17111503), the frequency of A allele was higher in CIS than in control participants (P=0.028, 39.80% *vs.* 32.66%) in the Han group, indicating that the risk of CIS was increased with the A allele of rs17111503. For SNP2 (rs2479408), the distribution of alleles, the dominant model (CC *vs.* CG + GG), and the additive model (CG *vs.* CC + GG) showed a significant difference between CIS and control participants in total and Han groups, but not in the Uygur group. C allele of rs2479408 was significantly higher in CIS patients than in control participants (total: 96.94% *vs.* 94.97%; Han: 99.80% *vs.* 98.24%). Moreover, the significant difference of the dominant model (CC *vs.* CG + GG) of rs2479408 was retained after adjustment for covariates: age, sex, BMI, HDL-C, LDL-C, TC, TG, ApoA1 ApoB, ApoLpa, EH, DM, and smoking and drinking in the Han group (OR: 75.262, 95% confidence interval \[CI\]: 7.232--783.278, P\<0.001), indicating that the risk of CIS was increased with the C allele of rs2479408. For SNP3 (rs529787), the distribution of alleles, the dominant model (CC *vs.* CG + GG), and the additive model (CG *vs.* CC + GG) showed a significant difference between CIS and control participants in total and Han groups, but not in Uygurs. C allele of rs529787 was significantly higher in CIS patients than in control participants (total: 96.81% *vs.* 94.68%; Han: 99.80% *vs.* 97.99%). When we constructed the haplotypes using SNP1 and SNP2, we found that the most frequent haplotype in this study was A-C haplotype. For Han, the frequency of A-C was significantly higher in the CIS patients than in the control subjects (P=0.0011), but the frequency of the G-C haplotype was lower in the CIS patients than in the control subjects (P=0.0011). This fully showed that A allele of rs17111503 and C allele of rs2479408 may be the risk factor of CIS, and G allele of rs17111503 and G allele of rs2479408 may be the protective factor of CIS.

SNP20 (rs505151) was observed in the exon12 of the PCSK9 gene and the polymorphisms caused the substitution of glutamate for a glycine residue at position 670 in the protein. The studies about the association between rs505151 of PCSK9 gene polymorphisms (E670G) and the cardiovascular risk have provided inconsistent results, as the introduction of description. Our study was consistent with previous studies \[[@b14-medscimonit-20-1758]--[@b16-medscimonit-20-1758]\] showing no significant association between the polymorphism of PCSK9 (rs505151) and CIS. By comparison, we found the age of our control subjects was higher than the other studies \[[@b11-medscimonit-20-1758],[@b12-medscimonit-20-1758]\] and the study by Afef Slimani \[[@b35-medscimonit-20-1758]\]. In our study, there were no significant difference in age between CIS patients (age: 63.56±11.37) and control subjects (age: 62.35±11.79) (P=0.269), but in the study by Afef Slimani, there were significant difference in age between CIS patients (age: 66/54.5--76.50) and control subjects (age: 49/45--55) (P\<0.0001). Age is a risk factor for stroke, and this may be why our conclusions were not consistent with their conclusions. In addition, there may be differences in populations and geographical factors that explain some differences.

Conclusions
===========

We found that both rs1711503 and 2479408 of PCSK9 were associated with CIS in the Han population of China. A-C haplotype may be a risk genetic marker of CIS in Han in China. A allele of rs17111503 and C allele of rs2479408 may be the risk marker of CIS. Studies with statistically significant numbers of clinical samples are needed for further research in China.
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Genotype and allele distributions of the twenty SNPs in patients with CIS and control subjects.

       SNP           Chr. 1 postion                  Function                 dbSNP allele   MAF                      Total   Han   Uygur                                       
  ---- ------------- ---------------- -------------- ------------------------ -------------- -------- ---------- ---- ------- ----- --------- ----- ----- --------- ----- ----- -------
  1    rs17111503    55503448         5′ near gene   Upstream variant 2KB     A/G            0.3375   Genotype   AA   81      59    0.223     42    22    0.094     39    37    0.757
       SNP1                                                                                                      AG   197     158   115       86    82    72                    
                                                                                                                 GG   130     131   93        91    37    40                    
                                                                                                      Allele     A    359     276   0.088     199   130   0.028\*   160   146   0.684
                                                                                                                 G    457     420   301       268   156   152                   
  2    rs2479408     55504118         5′ near gene   Upstream variant 2KB     C/G            0.1708   Genotype   CC   385     314   0.064     249   192   0.013\*   136   122   0.446
       SNP2                                                                                                      CG   21      33    1         7     20    36                    
                                                                                                                 GG   2       1     0         0     2     1                     
                                                                                                      Allele     C    791     661   0.050     499   391   0.013\*   292   270   0.423
                                                                                                                 G    25      35    1         7     24    28                    
       rs2479409     55504650         5′ near gene   Upstream variant 2KB     A/G            0.4362   Genotype   AA   75      58    0.789     34    24    0.864     41    34    0.715
  3    SNP3                                                                                                      AG   190     162   110       87    80    75                    
                                                                                                                 GG   143     128   106       88    37    40                    
                                                                                                      Allele     A    340     278   0.496     178   135   0.599     162   143   0.416
                                                                                                                 G    476     418   322       263   154   155                   
  4    rs11583680    55505668         Exon 1         Missense (V-A)           T/C            0.0905   Genotype   CC   328     280   0.237     194   159   0.099     134   121   0.673
       SNP4                                                                                                      CT   78      62    56        37    22    25                    
                                                                                                                 TT   2       6     0         3     2     3                     
                                                                                                      Allele     C    734     622   0.710     444   355   0.850     290   267   0.350
                                                                                                                 T    82      74    56        43    26    31                    
  5    rs10888896    555509213        Intron 1       Intron variant           C/G            0.2374   Genotype   CC   326     280   0.797     203   169   0.360     123   111   0.782
       SNP5                                                                                                      CG   76      61    45        27    31    34                    
                                                                                                                 GG   6       7     2         3     4     4                     
                                                                                                      Allele     C    728     621   0.995     451   365   0.436     277   256   0.521
                                                                                                                 G    88      75    49        33    39    42                    
  6    rs4927193     55509872         Intron 2       Intron variant           C/T            0.1377   Genotype   CC   2       5     0.347     0     3     0.097     2     2     0.863
       SNP6                                                                                                      CT   82      64    59        39    23    25                    
                                                                                                                 TT   324     279   191       157   133   122                   
                                                                                                      Allele     C    86      74    0.953     59    45    0.818     27    29    0.609
                                                                                                                 T    730     622   441       353   289   269                   
  7    rs499718      55512549         Intron 3       Intron variant           C/T            0.247    Genotype   CC   276     240   0.829     154   130   0.564     122   110   0.778
       SNP7                                                                                                      CT   116     97    86        64    30    33                    
                                                                                                                 TT   16      11    10        5     6     6                     
                                                                                                      Allele     C    668     577   0.570     394   324   0.332     274   253   0.520
                                                                                                                 T    148     119   106       74    42    45                    
  8    rs529787      55513521         Intron 3       Intron variant           C/G            0.1166   Genotype   CC   384     312   0.049\*   249   191   0.006\*   135   121   0.452
       SNP8                                                                                                      CG   22      35    1         8     21    27                    
                                                                                                                 GG   2       1     0         0     2     1                     
                                                                                                      Allele     C    790     659   0.039\*   499   390   0.006\*   291   269   0.426
                                                                                                                 G    26      37    1         8     25    29                    
  9    rs11206514    55516004         Intron 3       Intron variant           A/C            0.4096   Genotype   AA   248     212   0.670     152   124   0.899     96    88    0.727
       SNP9                                                                                                      AC   141     115   89        67    52    48                    
                                                                                                                 CC   19      21    9         8     10    13                    
                                                                                                      Allele     A    637     539   0.772     393   315   0.842     244   224   0.551
                                                                                                                 C    179     157   107       83    72    74                    
  10   rs572512      55517344         Intron 3       Intron variant           C/T            0.4596   Genotype   CC   54      40    0.711     26    14    0.365     28    26    0.993
       SNP10                                                                                                     CT   171     144   102       78    69    66                    
                                                                                                                 TT   183     164   122       107   61    57                    
                                                                                                      Allele     C    279     224   0.469     154   106   0.171     125   118   0.991
                                                                                                                 T    537     472   346       292   191   180                   
  11   rs2479413     55518682         Intron 5       Intron variant           C/T            0.3191   Genotype   CC   225     193   0.090     141   124   0.183     84    69    0.054
       SNP11                                                                                                     CT   150     140   95        70    55    70                    
                                                                                                                 TT   33      15    14        5     19    10                    
                                                                                                      Allele     C    600     526   0.363     377   318   0.109     223   208   0.834
                                                                                                                 T    216     170   123       80    93    90                    
  12   rs7552841     55518752         Intron 5       Intron variant           C/T            0.284    Genotype   CC   264     235   0.602     176   143   0.886     88    92    0.502
       SNP12                                                                                                     CT   126     96    65        48    61    48                    
                                                                                                                 TT   18      17    9         8     9     9                     
                                                                                                      Allele     C    654     566   0.564     417   334   0.834     237   232   0.406
                                                                                                                 T    162     130   83        64    79    66                    
  13   rs557435      55520864         Intron 5       Intron variant           A/G            0.1662   Genotype   AA   5       1     0.242     1     0     0.668     4     1     0.260
       SNP13                                                                                                     AG   56      56    32        25    24    31                    
                                                                                                                 GG   347     291   217       174   130   117                   
                                                                                                      Allele     A    66      58    0.862     34    25    0.755     32    33    0.703
                                                                                                                 G    750     638   466       373   284   265                   
  14   rs693668      55521109         Intron 5       Intron variant           A/G            0.3912   Genotype   AA   212     189   0.772     131   116   0.441     81    73    0.908
       SNP14                                                                                                     AG   164     135   100       71    64    64                    
                                                                                                                 GG   32      24    19        12    13    12                    
                                                                                                      Allele     A    588     513   0.472     362   303   0.205     226   210   0.774
                                                                                                                 G    228     183   138       95    90    88                    
  15   R434W         5552339?         Exon 8         Missense (R-W)           C/T            /        Genotype   CC   408     348             250   199             158   149   
       SNP15                                                                                                     CT                                                             
                                                                                                                 TT                                                             
                                                                                                      Allele     C    816     696             500   199             316   298   
                                                                                                                 T                                                              
  16   rs540796      55524197         Exon 9         Synonymous codon (V-V)   G/A            0.1354   Genotype   AA   1       2     0.585     0     0     0.716     1     2     0.340
       SNP16                                                                                                     AG   29      20    5         5     24    25                    
                                                                                                                 GG   378     326   245       194   133   132                   
                                                                                                      Allele     A    31      24    0.716     5     5     0.714     26    19    0.378
                                                                                                                 G    785     672   495       393   290   279                   
  17   rs149311926   55525315         Exon 10        Missense (E-Q)           G/C            0.0005   Genotype   CC   408     348             250   199             158   149   
       SNP17                                                                                                     CG                                                             
                                                                                                                 GG                                                             
                                                                                                      Allele     C    816     696             500   398             316   298   
                                                                                                                 G                                                              
  18   rs483462      55525400         Intron 10      Intron variant           A/G            0.3223   Genotype   AA   279     234   0.939     170   135   0.907     109   99    0.837
       SNP18                                                                                                     AG   116     102   73        57    43    45                    
                                                                                                                 GG   13      12    7         7     6     5                     
                                                                                                      Allele     A    674     570   0.721     413   327   0.863     261   243   0.734
                                                                                                                 G    142     126   87        71    55    55                    
  19   rs10465832    55528807         Intron 11      Intron variant           C/G            0.1483   Genotype   CC   2       3     0.778     1     2     0.654     1     1     0.419
       SNP19                                                                                                     CG   75      67    54        39    21    28                    
                                                                                                                 GG   331     278   195       158   136   120                   
                                                                                                      Allele     C    79      73    0.603     56    43    0.850     23    30    0.218
                                                                                                                 G    737     623   444       355   293   268                   
  20   rs505151      55529187         Exon 12        Missense (E-G)           A/G            0.0983   Genotype   AA   365     310   0.878     219   179   0.537     146   131   0.399
       SNP20                                                                                                     AG   41      37    30        20    11    17                    
                                                                                                                 GG   2       1     1         0     1     1                     
                                                                                                      Allele     A    771     657   0.940     468   378   0.380     303   279   0.207
                                                                                                                 G    45      39    32        20    13    19                    

###### 

Characteristics of study participants.

                    Total           Han             Uygur                                                                                                                                                                                      
  ----------------- --------------- --------------- ------------------------------------------------------------- --------------- --------------- ------------------------------------------------------------- --------------- -------------- -------------------------------------------------------------
  Number (n)        408             348                                                                           250             199                                                                           158             149            
  Sex(M/W)          242/166         183/165         0.063                                                         144/106         102/97          0.183                                                         98/60           81/68          0.203
  Age (years)       61.97±11.80     61.84±11.65     0.885                                                         63.56±11.37     62.35±11.79     0.269                                                         59.44±12.01     61.17±11.45    0.198
  BMI (kg/m^2^)     24.67±3.36      24.51±2.93      0.508                                                         24.30±3.30      24.20±3.13      0.728                                                         25.23±3.37      24.93±2.60     0.386
  Glu (mmol/L)      6.90±3.30       5.45±2.68       \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   6.86±3.12       5.24±1.44       \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   6.98±3.55       5.74±3.73      \<0.003[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  TG (mmol/L)       1.90±1.12       2.04±1.30       0.122                                                         1.81±1.08       1.90±1.21       0.406                                                         2.03±1.17       2.22±1.40      0.221
  TC (mmol/L)       4.38±0.96       4.27±1.24       0.182                                                         4.35±0.95       4.43±1.24       0.444                                                         4.42±0.98       4.06±1.22      0.004[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  HDL (mmol/L)      1.05±0.35       1.36±0.90       \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   1.07±0.26       1.35±0.84       \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   1.02±0.44       1.37±0.98      \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  LDL (mmol/L)      2.76±0.88       2.52±0.78       \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   2.68±0.86       2.51±0.78       0.038[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}     2.87±0.89       2.52±0.79      \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  ApoA1 (mmol/L)    1.25±0.27       1.22±0.35       0.216                                                         1.27±0.22       1.24±0.30       0.310                                                         1.21±0.32       1.18±0.40      0.538
  ApoB (mmol/L)     0.89±0.76       0.89±0.61       0.909                                                         0.90±0.75       0.90±0.79       0.986                                                         0.87±0.24       0.88±0.23      0.612
  ApL(a) (mmol/L)   195.27±146.14   172.94±113.84   0.019[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}     199.72±146.08   192.68±136.62   0.602                                                         188.20±146.42   146.57±64.73   0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  EH (Y/N)          284/118         98/246          \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   175/72          54/143          \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   129/46          44/103         \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}
  DM (Y/N)          125/269         65/272          \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   78/164          31/168          \<0.001[\*](#tfn2-medscimonit-20-1758){ref-type="table-fn"}   47/105          34/104         0.242
  Smoke (Y/N)       117/279         86/250          0.234                                                         79/169          51/144          0.208                                                         38/110          35/106         0.893
  Drinking(Y/N)     0.204           44/290          0.161                                                         43/204          26/167          0.292                                                         23/120          18/123         0.500

BMI -- body mass index; BUN -- blood urea nitrogen; Glu -- glucose; TG -- triglyceride; TC -- total cholesterol; HDL -- high density lipoprotein; LDL -- low density lipoprotein; EH -- essential hypertension; DM -- diabetes mellitus. Continuous variable were expressed as mean ± standard deviation. P value of continuous variables was calculated by independent T-T test. The P value of categorical variable was calculated by Fisher's exact test.

P\<0.05.

###### 

Pairwise linkage disequilibrium (\| D'\| above diagonal and r*^2^* below diagonal) for the three SNPs.

         Total   Han     Uygur                                                                 
  ------ ------- ------- ------- ------- ------ ------- ------- ------- ------ ------- ------- -------
  r^2^   SNP1            0.999   0.999   SNP1           1.000   0.988   SNP1           0.999   0.999
         SNP2    0.057           0.983   SNP2   0.016           1.000   SNP2   0.093           0.979
         SNP8    0.060   0.918           SNP3   0.017   0.888           SNP8   0.097   0.919   

###### 

Haplotype analysis of the two SNPs (rs17111503 and rs2479408).

          Haplotype        Case (freq)      Control (freq)           Odds Ratio \[95% CI\]    P
  ------- ---------------- ---------------- ------------------------ ------------------------ ---------
  Total   AC               334.02 (0.409)   241.01 (0.346)           1.308 \[1.061--1.613\]   0.012\*
  AG      24.98 (0.031)    34.99 (0.050)    0.597 \[0.353--1.007\]   0.051                    
  GC      456.98 (0.560)   419.99 (0.603)   0.837 \[0.681--1.027\]   0.088                    
  GG      0.02 (0.000)     0.01 (0.000)                                                       
  Han     AC               198.05 (0.396)   123.00 (0.309)           1.434 \[1.085--1.895\]   0.011\*
  AG      0.95 (0.002)     7.00 (0.018)                                                       
  GC      300.95 (0.602)   268.00 (0.673)   0.697 \[0.528--0.922\]   0.011\*                  
  GG      0.05 (0.000)     0.00 (0.000)                                                       
  Uygur   AC               136.01 (0.430)   118.01 (0.396)           1.153 \[0.836--1.590\]   0.387
  AG      23.99 (0.076)    27.99 (0.094)    0.792 \[0.448--1.401\]   0.423                    
  GC      155.99 (0.494)   151.99 (0.510)   0.936 \[0.682--1.285\]   0.685                    
  GG      0.01 (0.000)     0.01 (0.000)                                                       

All those frequency\<0.03 will be ignored in analysis.

###### 

Multiple logistic regression analysis for stoke patients and control subjects.

                         Total    Han     Uygur                                                                            
  ---------------------- -------- ------- -------- --------- -------- ------- --------- --------- ------- ------- -------- -------
  rs2479408 (CC/CG+GG)   10.544   3.336   33.328   0.000\*   75.262   7.232   783.278   0.000\*   2.229   0.449   11.060   0.327
  sex                    10.544   3.336   33.328   0.613     1.147    0.651   2.019     0.635     1.045   0.558   1.956    0.891
  age                    1.001    0.986   1.016    0.901     0.997    0.976   1.018     0.762     1.017   0.991   1.043    0.196
  BMI                    0.981    0.924   1.041    0.522     0.983    0.905   1.068     0.686     0.987   0.897   1.086    0.789
  TG                     1.109    0.953   1.291    0.181     1.228    0.981   1.537     0.073     1.118   0.882   1.418    0.356
  TC                     1.031    0.851   1.250    0.756     1.239    0.933   1.646     0.139     0.715   0.508   1.008    0.055
  HDL-C                  1.783    1.288   2.468    0.000\*   2.568    1.413   4.666     0.002\*   1.297   0.854   1.970    0.223
  LDL-C                  0.685    0.528   0.889    0.004\*   0.660    0.453   0.961     0.030\*   0.752   0.483   1.169    0.205
  APOA1                  0.990    0.556   1.762    0.974     0.744    0.269   2.061     0.570     1.348   0.617   2.945    0.453
  APOB                   1.103    0.889   1.370    0.373     1.114    0.873   1.421     0.388     1.292   0.380   4.392    0.681
  APL (a)                0.999    0.997   1.000    0.061     0.999    0.997   1.001     0.225     0.996   0.993   1.000    0.031
  EH                     5.308    3.700   7.615    0.000\*   6.366    3.877   10.453    0.000\*   5.112   2.836   9.215    0.000
  DM                     2.407    1.546   3.746    0.000\*   4.746    2.403   9.376     0.000\*   1.379   0.717   2.655    0.336
  Smoking                1.137    0.656   1.972    0.647     1.133    0.542   2.370     0.739     0.956   0.376   2.433    0.925
  Drinking               8.645    3.174   23.549   0.000\*   52.408   5.808   472.912   0.000\*   1.883   0.495   7.165    0.353
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